This article has been updated to include comments from Illumina's conference call.

NEW YORK (GenomeWeb) – Illumina reported after the close of the market today that its first quarter 2015 revenues grew 28 percent year over year, and on a constant currency basis were up 33 percent.

The San Diego-based firm reported total Q1 2015 revenues of $538.6 million compared to $420.8 million in Q1 2014. It beat the average analyst estimate of $524.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.